It should also be mentioned that the described FRET probe is not suitable for drugs that kill cancer cells through caspase-independent mechanisms or drugs that kill cells through activation of caspases other than caspase 3 or 8, such as caspase 2 mediated apoptosis or necroptosis. Here, CASP2 is linked to cancer.